Nova Mentis Life Science Corp (TSE:NOVA) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nova Mentis Life Science Corp., a Canadian biotech leader in neuroinflammatory diagnostics and therapeutics, has announced the addition of experienced entrepreneur Steve Loutskou to its Board of Directors. Loutskou, known for his strategic vision and financial expertise, has a track record of advancing start-ups and attracting investments. His appointment is expected to bolster Nova’s business strategies and operations.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.